These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 25074437

  • 1. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT, Barden HL, Baguley IJ.
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [Abstract] [Full Text] [Related]

  • 2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 4. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P, Mochizuki G, Dutta T, Richardson D, Brooks D.
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [Abstract] [Full Text] [Related]

  • 5. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, Hughes A.
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [Abstract] [Full Text] [Related]

  • 6. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 7. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 8. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Mar 31; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 9. Dynamic computerised hand dynamometry: measuring outcomes following upper limb botulinum toxin-A injections in adults with acquired brain injury.
    Barden HL, Baguley IJ, Nott MT, Chapparo C.
    J Rehabil Med; 2014 Apr 31; 46(4):314-20. PubMed ID: 24531305
    [Abstract] [Full Text] [Related]

  • 10. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M, Brand C, Louie J, Khan F.
    J Rehabil Med; 2016 Apr 28; 48(5):426-34. PubMed ID: 27097568
    [Abstract] [Full Text] [Related]

  • 11. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A, Vallies G, Chemello E, Gavras A, Castellazzi P, Meschieri A, Serina A, Gandolfi M, Baricich A, Santamato A, Cisari C, Smania N.
    J Rehabil Med; 2017 May 16; 49(5):410-415. PubMed ID: 28471469
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F.
    J Rehabil Med; 2014 Sep 16; 46(8):730-7. PubMed ID: 25073939
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.
    J Rehabil Med; 2009 Jun 16; 41(7):536-44. PubMed ID: 19543664
    [Abstract] [Full Text] [Related]

  • 14. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K.
    BMJ Open; 2016 Jun 17; 6(6):e011157. PubMed ID: 27315835
    [Abstract] [Full Text] [Related]

  • 15. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 17; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 16. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP, Pinto D, Gorayeb M, Jacinto J.
    Top Stroke Rehabil; 2018 Apr 17; 25(3):194-202. PubMed ID: 29322885
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 18. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.
    J Rehabil Med; 2011 Nov 24; 43(11):1032-7. PubMed ID: 22031350
    [Abstract] [Full Text] [Related]

  • 19. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Nov 24; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 20. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.